Physician profile
Gregory E Dean
NPI 1447226139
$8,251.71
in general payments reported to CMS, 2019-2025
12 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,652 · 2020: $604 · 2021: $367 · 2022: $243 · 2023: $62.99 · 2024: $2,136 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,488 · Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,487.50 |
| Food and Beverage | $897.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $4,492.69 | 2019-2023 | Bard Urinary Drainage Bag |
| Novo Nordisk INC | $1,819.28 | 2024-2025 | Rivfloza |
| Palette Life Sciences, INC. | $979.83 | 2019-2022 | |
| Teleflex LLC | $282.53 | 2024 | Deflux |
| Rochester Medical Corporation | $175.33 | 2019-2020 | |
| Novo Nordisk Health Care Ag | $124.28 | 2024 | |
| Boston Scientific Corporation | $117.26 | 2019 | |
| Hollister Incorporated | $110.60 | 2021 | |
| Coloplast Corp | $62.16 | 2025 | |
| 180 Medical, INC. | $34.25 | 2024 | Gentlecath |
| Alnylam Pharmaceuticals INC. | $34.05 | 2020-2023 | Oxlumo |
| Abbvie INC. | $19.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.